In addition, a strong link between IL-6-STAT3 signaling and O6-methylguanine DNA methyl transferase expression and methylation and to temozolomide sensitivity in glioblastoma was found, suggesting a possible combination therapeutic approach based on IL-6/STAT3 inhibitors [33,34]. The gene discussed is IL6; the disease is glioblastoma.